Text Size
321 studies found for:    Baxter

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration
Condition: End Stage Kidney Disease
Intervention: Device: Dialyzer Baxter Xenium XPH 210
2 Not yet recruiting Safety and Efficacy Evaluation of Two Kinds of Peritoneal Dialysate
Condition: Kidney Failure,Chronic
Interventions: Drug: Huaren Peritoneal Dialysate;   Drug: Baxter Peritoneal Dialysate
3 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
4 Completed Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
Condition: Chronic Renal Failure
Intervention: Device: Baxter’s UltraBag® and FMC Andy·Disc®
5 Completed Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free
6 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
7 Completed Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers
Condition: End Stage Renal Failure on Dialysis
Intervention:
8 Not yet recruiting Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery
Condition: Postoperative Abdominal Surgery for Cancer
Interventions: Dietary Supplement: Early parenteral nutrition (Baxter n7);   Dietary Supplement: Late parenteral nutrition (Baxter n7)
9 Completed
Has Results 		Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Biological: Immune Globulin Intravenous (human), 10%;   Biological: 0.25% human albumin solution (Placebo)
10 Recruiting Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery
Condition: Adolescent Idiopathic Scoliosis
Intervention: Device: Gelatin matrix with human derived thrombin (Floseal, Baxter)
11 Completed FSME IMMUN NEW Follow-Up to Study 205 in Children Aged 6 to 16 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
12 Completed FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
13 Enrolling by invitation Long-Term Study of IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Intervention: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%)
14 Completed
Has Results 		Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free
15 Active, not recruiting Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
Conditions: ALL;   ANLL;   MDS;   NHL
Interventions: Procedure: Naive T-cell Depleted Stem Cell Transplantation;   Other: Control Arm: Stem Cell Transplant No Manipulation;   Device: Isolex device from Baxter
16 Active, not recruiting Tolerability and Safety of Immune Globulin Subcutaneous Solution and rHuPH20 in Primary Immunodeficiency Diseases (PID)
Condition: Primary Immunodeficiency Diseases (PID)
Intervention: Biological: Immune Globulin Subcutaneous Solution (IGSC)
17 Completed Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
Conditions: Acute Appendicitis;   Perforated Gastroduodenal Ulcer;   Small Bowel Obstruction
Interventions: Drug: Metronidazole, Cefuroxime;   Drug: Amoxicillin (+ clavulanic acid) and Fluconazole;   Drug: Placebo
18 Completed
Has Results 		Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery
Conditions: Cystoscopes;   Baxter Anaesthesia Brand of Desflurane;   Sevoflurane
Interventions: Drug: Desflurane;   Drug: Sevoflurane
19 Completed
Has Results 		Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection
Condition: Bleeding (Oozing) in Hepatic Resection
Interventions: Drug: Fibrin Sealant (FS) VH S/D 500 s-apr;   Other: Manual compression
20 Recruiting BAX 326 (rFIX) Continuation Study
Condition: Hemophilia B
Intervention: Biological: BAX 326 (Recombinant factor IX)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years